BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 38700714)

  • 1. Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia.
    Zhang X; Guo X
    Thromb J; 2021 Jun; 19(1):42. PubMed ID: 34130694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features.
    Breccia M; Avvisati G; Latagliata R; Carmosino I; Guarini A; De Propris MS; Gentilini F; Petti MC; Cimino G; Mandelli F; Lo-Coco F
    Leukemia; 2007 Jan; 21(1):79-83. PubMed ID: 16932337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction].
    Zhu HH; Liu YR; Qin YZ; Li JL; Chang Y; Wang YZ; Shan FX; Jiang B; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):1-5. PubMed ID: 17490509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The First Switched Time of PML/RARĪ± Fusion Gene in Patients with Acute Promyelocytic Leukemia and Its Clinical Significance].
    Pu LF; Tao QS; Wang HP; Zhai ZM; Xiong SD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1551-5. PubMed ID: 26708869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical risk factors and outcomes of acute promyelocytic leukemia patients with thrombotic events: a matched pair analysis.
    Song X; Chi C; Gao W; Sun W; Liu Y; Zhang X; Huang X; Zhu J; Wang Y
    J Thromb Thrombolysis; 2024 May; ():. PubMed ID: 38700714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
    Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute promyelocytic leukemia: state-of-the-art management].
    Asou N
    Rinsho Ketsueki; 2018; 59(6):725-734. PubMed ID: 29973452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis in acute promyelocytic leukemia.
    Rashidi A; Silverberg ML; Conkling PR; Fisher SI
    Thromb Res; 2013 Apr; 131(4):281-9. PubMed ID: 23266518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
    Jing Y
    Leuk Lymphoma; 2004 Apr; 45(4):639-48. PubMed ID: 15160934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.